Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area
News Oct 22, 2007
Salugen® has announces a partnership with DNA Dimensions of Southfield, Michigan to distribute Salugen's nutritional gene testing and DNA-customized nutritional solutions in metro Detroit. DNA Dimensions will offer GenoTrim®, a DNA-customized nutritional solution for weight management, along with other products from Salugen.
"DNA Dimensions is the only DNA testing company with 14 offices around metro Detroit so we have convenient locations. By being locally owned, DNA Dimensions is part of the community we serve, which shows we care about our customers and provide superior customer service," said Mike Pickett, DNA Dimensions owner.
Mr. Pickett went on to state, "We are proud to have formed a partnership with Salugen. Unlike other companies involved in Nutrigenetics, Salugen has hundreds of publications in peer-reviewed scientific journals to support its products."
"By having DNA Dimensions locations throughout metro Detroit working with patients, local laboratories, physicians, and hospitals, Salugen's products and services will be made available right where people need it most, in their community," states Lonna J. Williams, Salugen COO and SVP of Marketing and Sales.
"Through this partnership, we hope to help people who suffer from certain healthcare conditions to better understand the causes of those conditions and gain access to DNA-customized dietary supplementation to support their health."
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.